NeoGenomics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NG9.F | PSNL | BLLN | MYGN | NTRA | CSTL | |
|---|---|---|---|---|---|---|
| Market cap | 1.95B | 1.69B | 5.37B | 575.81M | 56.36B | 1.09B |
| P/E (TTM) | — | — | 180.8 | — | — | — |
| Forward P/E | -94.3 | -16.3 | 76.7 | -10.2 | -2,198.8 | -38.2 |
| Price/book | 2.7 | 6.2 | 9.9 | 1.9 | 30.8 | 2.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +66.38% | +105.61% | +1.39% | −8.21% | +94.39% | +4.68% |
| Today | +1.89% | +0.25% | +3.11% | −0.33% | +0.62% | +1.74% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All NG9.F news ›NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology
NeoGenomics, Inc. (NASDAQ: NEO), a provider of oncology diagnostic solutions that enable precision medicine across the cancer care continuum, has expanded its partnership with Indica Labs, a global ... FORT MYERS, Fla.--(BUSINESS…
NeoGenomics raises 2026 guidance to $807M-$809M while planning CEO transition in January 2027
NeoGenomics Q3 2026: revenue rose 11%, NGS surged, and guidance increased. Earnings Call Insights: NeoGenomics (NEO) Q3 2026 - "Clinical revenue grew 13% year-over-year. NGS revenue grew a strong 29%, and our adjusted gross margins…
NeoGenomics Reports Third Quarter 2026 Results
Total revenue increased 11% YoY to $209 million Clinical services revenue grew 13%, with NGS revenue growth of 29% Company raises full-year 2026 revenue and adjusted EBITDA guidance FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc.…
NeoGenomics, Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-10-30. The following slide deck was published by NeoGenomics, Inc. The following slide deck was published by NeoGenomics, Inc. in conjunction with their 2026 Q3 earnings call. Q3: 2026-10-28 Earnings Summary
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
Wed, Oct. 28, 2026 Operator: Good afternoon, and welcome to the NeoGenomics Third Quarter 2026 Financial Results Conference Call. Please be advised that today's conference is being recorded. I will now turn the call over to Andrew…
More from 1 other outlet
NeoGenomics, Inc. Announces Chief Executive Officer Changes, Effective January 4, 2027
NeoGenomics, Inc. announced that as part of a planned succession, its Board of Directors has appointed Warren Stone, current President and Chief Operating Officer , as Chief Executive Officer ,... announced that as part of a planned…
NeoGenomics, Inc. Provides Financial Guidance for the Third Quarter Ended September 30, 2026; Reiterates Financial Guidance for the Full Year 2026
NeoGenomics, Inc. provided financial guidance for the third quarter ended September 30, 2026. Although the company has not finalized its financial results as of and for the quarter ended September 30,... provided financial guidance for the…
Neogenomics, Inc. Announces Resignation of Alicia Olivo from General Counsel Role, Effective September 21, 2026
NeoGenomics, Inc. announced that Alicia Olivo, EVP, General Counsel & Business Development, would transition from her role with the Company and cease to serve as General Counsel effective as of... Published on 08/11/2026 at 04:10 pm EDT…
NeoGenomics names Warren Stone CEO effective Jan. 4, 2027
NeoGenomics, Inc. (NASDAQ: NEO) is a cancer diagnostics company specializing in oncology genetics testing and information services with labs in the US and UK. NeoGenomics names Warren Stone CEO effective Jan. 4, 2027 The full-year revenue…
More from 1 other outlet
NeoGenomics COO exercises stock units for 17,562 shares
NeoGenomics, Inc. (NASDAQ: NEO) is a cancer diagnostics company specializing in oncology genetics testing and information services with labs in the US and UK. NeoGenomics COO exercises stock units for 17,562 shares The president and COO…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com8
- seekingalpha.com4
- tradingview.com3
- biospace.com2
- genomeweb.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 34 articles, not a forecast.